Alternatives potentielles à la transfusion érythrocytaire dans les hémoglobinopathies : hydroxyurée (HU), érythropoïétine (EPO), dérivés du butyrate, substituts du sang-Reference-Cited by-同舟云学术

Alternatives potentielles à la transfusion érythrocytaire dans les hémoglobinopathies : hydroxyurée (HU), érythropoïétine (EPO), dérivés du butyrate, substituts du sang

Published:1994-01 Issue:1 Volume:1 Page:35-39
ISSN:1246-7820
Container-title:Transfusion Clinique et Biologique
language:fr
Short-container-title:Transfusion Clinique et Biologique

Author:

Bachir D.,Galacteros F.

Publisher

Elsevier BV

Subject

Biochemistry, medical,Clinical Biochemistry,Hematology

Reference17 articles.

1. La transfusion dans la drépanocytose. Proposition du groupe d'étude sur la drépanocytose, réseau INSERM. « Etude épidémiologique de la drépanocytose en région parisienne;Bachir;Press Med,1990

2. For debate : Bone marrow transplantation for severe thalassaemia;Lucarelli;Br. J. Hematol.,1991

3. Bone marrow transplation for severe sickle cell anaemia;Ferster;Brit. J. Haemat.,1992

4. Bone marrow transplantation (BMT) in 14 children with severe sickle cell disease (SCD) : the french experience;Bernaudin;BMT,1993

5. Nouvelles approches dans le traitement des hémoglobinopathies;Gluckman,1991

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transfusion Management in Sickle Cell Disease;Hematology/Oncology Clinics of North America;2005-10

2. Role of butyric acid and its derivatives in the treatment of colorectal cancer and hemoglobinopathies;Life Sciences;1998-10

3. Leg ulceration in the sickle cell patient;Journal of the American College of Surgeons;1998-09

4. 9 Pharmacological therapy;Baillière's Clinical Haematology;1998-03

5. Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease;Blood;1996-02-01